CDK4/6 inhibitors

You have access
Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR⁺/HER2⁻ Metastatic Breast Cancer on CDK4/6 Inhibitor
YUMIKO KOI, WAKAKO TAJIRI, JUNJI KAWASAKI, SAYURI AKIYOSHI, HIDEKI IJICHI, YOSHIAKI NAKAMURA, CHINAMI KOGA and ERIKO TOKUNAGA

Anticancer Research December 2025, 45 (12) 5609-5618; DOI: https://doi.org/10.21873/anticanres.17895
You have access
Molecular Characterization and Therapeutic Implications of MYD88 and CDKN2A in Primary CNS Lymphoma
RYOUTA TAOMOTO, MIKIKO AOKI, TOSHIYUKI ENOMOTO, TOORU INOUE, KAZUKI NABESHIMA, MAKOTO HAMASAKI and HIROSHI ABE

Anticancer Research August 2025, 45 (8) 3441-3450; DOI: https://doi.org/10.21873/anticanres.17705
Open Access
Trametinib Synergized With Abemaciclib to Inhibit Tumor Growth in Human Head and Neck Squamous Cell Carcinoma Cells
ERNEST DUAH, MING POI and JUNAN LI

Anticancer Research June 2025, 45 (6) 2285-2295; DOI: https://doi.org/10.21873/anticanres.17603
You have access
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report
OFRA MAIMON, BENJAMIN NISMAN, SHANI BROIER, INNA BEN-DAVID, ANNA KUZNETZ, YAEL GELFAND, AVITAL MIZRAHI, EUGENIA PRUS, INBAL FUCHS, MICHAL LOTEM, ARON POPOVTZER, SALOME KHUTSURAULI, AMICHAY MEIROVITZ, HOVAV NECHUSHTAN and TAMAR PERETZ

Anticancer Research August 2024, 44 (8) 3543-3550; DOI: https://doi.org/10.21873/anticanres.17175
You have access
Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor
ANDREW HUNT, WAQAR HAQUE, RAMIRO PINO, ANDREW FARACH, E. BRIAN BUTLER and BIN S. TEH

Anticancer Research August 2023, 43 (8) 3539-3542; DOI: https://doi.org/10.21873/anticanres.16531

Main menu

User menu

Search

CDK4/6 inhibitors